These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10704653)

  • 21. Localization of fibrinogen during ADP- or thrombin-induced aggregation of washed rabbit platelets.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Mustard JF; Tanoue K; Yamazaki H
    J Histochem Cytochem; 1990 Jun; 38(6):869-74. PubMed ID: 2335742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggregation of gel-filtered guinea-pig platelets by lipoproteins.
    Fujitani B; Tsuboi T; Yoshida K; Shimizu M
    Thromb Haemost; 1979 Apr; 41(2):416-24. PubMed ID: 224521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of low doses of ethanol on platelet function in long-life abstainers and moderate-wine drinkers.
    Miceli M; Alberti L; Bennardini F; Di Simplicio P; Seghieri G; Rao GH; Franconi F
    Life Sci; 2003 Aug; 73(12):1557-66. PubMed ID: 12865095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of lipid peroxidation-modified lipoproteins on thrombocyte aggregation].
    Azizova OA; Vlasova II
    Biull Eksp Biol Med; 1993 Nov; 116(11):485-7. PubMed ID: 8312535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins.
    Korotaeva AA; Cheglakov IB; Morozkin AD; Suslova IV; Prokazova NV
    Membr Cell Biol; 1997; 10(5):521-34. PubMed ID: 9225256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA; Reimann S; Schrör K
    Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aggregation of human blood platelets by remnant-like lipoprotein particles].
    Umemura K; Saniabadi AR
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):269-74. PubMed ID: 11215376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomaterials induce oxidized low-density lipoprotein cellular uptake in macrophages and platelet aggregation.
    Niwa Y; Iwai N
    Circ J; 2007 Mar; 71(3):437-44. PubMed ID: 17322648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation.
    Aviram M; Fuhrman B; Keidar S; Maor I; Rosenblat M; Dankner G; Brook G
    J Clin Chem Clin Biochem; 1989 Jan; 27(1):3-12. PubMed ID: 2498457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine 5'-diphosphate as a factor in platelet aggregation induced by human plasma remnant lipoproteins.
    Saniabadi AR; Umemura K; Suzuki Y; Kondo K; Ikeda Y; Adachi M; Nakashima M
    Life Sci; 1998; 63(12):1065-74. PubMed ID: 9749829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
    Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion.
    Riddell DR; Owen JS
    Thromb Res; 1995 Dec; 80(6):499-508. PubMed ID: 8610278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C; Dubernard V; Caen J
    Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
    Pearce PH; Wright JM; Egan CM; Scrutton MC
    Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of aggregated immunoglobulins to the human platelet Fc receptors: a mechanism of platelet to platelet bridging.
    Parbtani A; Clark WF; Caveney A; Reid B
    Thromb Haemost; 1987 Dec; 58(4):966-70. PubMed ID: 3127922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro and ex-vivo inhibition of blood platelet aggregation by naftazone.
    Durand P; Bloy C; Peltier-Pujol F; Blache D
    J Pharm Pharmacol; 1996 Jun; 48(6):566-72. PubMed ID: 8832488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion.
    Riddell DR; Owen JS
    Thromb Res; 1996 Mar; 81(5):597-606. PubMed ID: 9054055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Domains in serum albumin responsible for platelet aggregation.
    Imada T; Saito Y; Inada Y
    FEBS Lett; 1981 Nov; 134(2):249-52. PubMed ID: 7308489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.